Effects of Vojta Therapy on Functional Mobility and Gait Parameters in Children With Down Syndrome

This randomized clinical trial provides a detailed effects of Vojta therapy on functional mobility and gait parameters in children with down syndrome. The study is grounded to evaluate the effects of vojta therapy on functional mobility and gait parameters in children with down syndrome. This RCT study will examine the potential key parameters of gait I.e its spacial parameters that are step length , stride length , stride width ,In and out toe and BOS and functional mobility and this study will add potential information in field of pediatrics by examining whether vojta therapy an effective therapeutic intervention over conventional therapeutic plan of care .The study will give the evidence based therapeutic intervention for improvement of DS patient's quality of life and overall mobility .study will be helpful for broader application of reflexive therapies if study will yield supporting results for treating children of down syndrome and their improving their alarming functional mobility and gait commodities.

The study will recruit 28 children with down syndrome between the ages of 2 and 10, who will be randomly assigned to either to control and experimental intervention group for a eight-week period. Performance will be measured using standardized tools that are GMFM 88 and gait outcomes parameters. These assessments will be conducted at baseline before the intervention begins and again immediately following the eight-week intervention given period. The collected data will be analyzed to evaluate the in-between differences of effects of intervention on both groups , with statistical adjustments for baseline values to ensure a robust comparison. The findings are expected to give the evidence based therapeutic intervention for improvement of DS patient's quality of life and overall mobility .study will be helpful for broader application of reflexive therapies if study will yield supporting results for treating children of down syndrome and their improving their alarming functional mobility and gait commodities. Data will be analyzed through SPSS version 27.00.

Inclusion criteria

• Age: 2-10 years old
• Confirmed diagnosis of Down syndrome by pediatric neurologist.
• Written informed consent obtained from parents or guardians.
• Independent standing and walking abilities assessed by GMFM dimension D and E.
• Functional hearing and vision, and understanding of instructions which were necessary for the measurement procedures
• No other physical therapy or interventions within the past three months

Exclusion criteria

• Presence of other significant medical conditions (e.g., severe cardiac issues).
• History of orthopedic surgery or significant musculoskeletal issues affecting mobility.
• Any additional neurological disorders that could confound results.
• Patient with Serious cognitive & behavior issues that would interfere with group participation.
• Participation in other clinical trials during the study period